コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 taneously or as part of a hereditary disease neurofibromatosis type 2.
2 first case of coexistence of gastrinoma with neurofibromatosis type 2.
3 ation of schwannoma tumours in patients with neurofibromatosis type 2.
4 aracterized by abnormal vasculature, such as neurofibromatosis type 2.
5 y benign, and are frequently associated with neurofibromatosis type 2.
6 the remainder acquire a de novo mutation for neurofibromatosis type 2.
7 ical findings, and management strategies for neurofibromatosis type 2.
9 nd hearing loss is a serious complication of neurofibromatosis type 2, a genetic condition associated
10 umours that occur in patients suffering from neurofibromatosis type 2, all spontaneous schwannomas an
11 refers to an Italian 69 year old woman with neurofibromatosis type 2 and a pancreatic gastrinoma.
12 om 21 vestibular schwannomas associated with neurofibromatosis type 2 and from 22 sporadic schwannoma
14 hearing in some, but not all, patients with neurofibromatosis type 2 and was associated with a reduc
15 xternal ophthalmoplegia, myotonic dystrophy, neurofibromatosis type 2, and basal cell nevus syndrome.
18 ive tumor suppressor protein associated with neurofibromatosis type 2, in the nucleus of some cells.
22 erlin/NF2 (moesin-ezrin-radixin-like protein/neurofibromatosis type 2) is a tumor suppressor found to
25 iology of neurofibromatosis type 1 (NF1) and neurofibromatosis type 2 (NF2) as they relate to the dev
26 thern blot analysis has shown that the human neurofibromatosis type 2 (NF2) cDNA hybridizes to multip
28 teral vestibular schwannomas associated with neurofibromatosis type 2 (NF2) experience significant mo
29 n the long arm of chromosome 22 and near the neurofibromatosis type 2 (NF2) gene (22q12) were most fr
45 ort here that liver-specific deletion of the neurofibromatosis type 2 (Nf2) tumor suppressor gene in
52 vant targets, we examined the role of YAP in neurofibromatosis type 2 (NF2) using cell and animal mod
53 uirement for the PAKs in the pathogenesis of Neurofibromatosis type 2 (NF2), a dominantly inherited c
55 ions in the merlin tumor suppressor underlie neurofibromatosis type 2 (NF2), a familial autosomal dom
56 function mutations or deletions in NF2 cause neurofibromatosis type 2 (NF2), a multiple tumor forming
57 s of expression of merlin is responsible for neurofibromatosis type 2 (NF2), which is characterized b
58 ene in a panel of 239 schwannoma tumours: 97 neurofibromatosis type 2 (NF2)-related schwannomas, 104
61 Merlin, the Drosophila homolog of the human Neurofibromatosis type-2 (NF2) tumor-suppressor gene, an
62 In humans, mutations in the NF2 gene cause neurofibromatosis type-2 (NF2), a cancer syndrome charac
67 hese actions of ezrin are antagonized by the neurofibromatosis type 2 tumor-suppressor protein merlin
68 examined from an additional 39 patients with neurofibromatosis type 2 who were retrospectively identi
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。